These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 903914)

  • 1. Synthesis and evaluation of alpha-hydroxythiol esters as antitumor agents and glyoxalase I inhibitors.
    Hall SS; Doweyko LM; Doweyko AM; Zilenovski JS
    J Med Chem; 1977 Oct; 20(10):1239-42. PubMed ID: 903914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents?
    Douglas KT; Nadvi IN
    FEBS Lett; 1979 Oct; 106(2):393-6. PubMed ID: 499526
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and evaluation of N-alkanoyl-S-benzyl-L-cysteinylglutamic acid esters as glyoxalase I inhibitors and anticancer agents.
    Foye WO; Jan CM
    J Pharm Sci; 1984 Apr; 73(4):559-61. PubMed ID: 6726645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glyoxalase I inhibitor of a new structural type produced by Streptomyces.
    Takeuchi T; Chimura H; Hamada M; Umezawa H; Yoshioka O
    J Antibiot (Tokyo); 1975 Oct; 28(10):737-42. PubMed ID: 1102510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glyoxalase I by various clinically used anticancer drugs.
    Kraus JL; Pernice P; Ponce C
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):419-22. PubMed ID: 3363227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal copoly(amino acids) as inhibitors of glyoxalase I.
    Fox SW; Syren RM; Windsor CR
    Ciba Found Symp; 1978; (67):175-93. PubMed ID: 259497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on liver glyoxalase I and glyoxalase II. Activity in mice bearing sarcoma 180 and L1210 leukemia.
    Winter R; Piskorska D; Jerzykowski T
    Neoplasma; 1978; 25(4):465-70. PubMed ID: 692805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial transition-state inhibitors of glyoxalase I from human erythrocytes, yeast and rat liver.
    Douglas KT; Gohel DI; Nadvi IN; Quilter AJ; Seddon AP
    Biochim Biophys Acta; 1985 May; 829(1):109-18. PubMed ID: 3888271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of glyoxalase I from porcine erythrocytes and yeast by amino-group reagents.
    Mannervik B; Marmstål E; Ekwall K; Górna-Hall B
    Eur J Biochem; 1975 May; 53(2):327-33. PubMed ID: 237756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of glyoxalase enzymes.
    Oray B; Norton SJ
    Biochem Biophys Res Commun; 1980 Jul; 95(2):624-9. PubMed ID: 7417280
    [No Abstract]   [Full Text] [Related]  

  • 11. A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides.
    Hamilton DS; Kavarana MJ; Sharkey EM; Eiseman JL; Creighton DJ
    J Med Chem; 1999 May; 42(10):1823-7. PubMed ID: 10346934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antineoplastics. 8. Synthesis and pharmacology of 6-methyl-2-thio-5-arylazouracils.
    Garg HG; Sharma RA
    J Med Chem; 1971 Dec; 14(12):1248. PubMed ID: 5165607
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and kinetic evaluation of S- and N-substituted cysteinylglycines as inhibitors of glyoxalase I.
    Lyon PA; Vince R
    J Med Chem; 1977 Jan; 20(1):77-88. PubMed ID: 833829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on glyoxalase I inhibitors.
    Barnard JF; Honek JF
    Biochem Biophys Res Commun; 1989 Nov; 165(1):118-24. PubMed ID: 2686643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of a glyoxalase I inhibitor and its chemical reactivity with SH-compounds.
    Chimura H; Nakamura H; Takita T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1975 Oct; 28(10):743-8. PubMed ID: 1184466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and study of glutaryl-S-(omega-aminoalkyl)-L-cysteinylglycines as inhibitors of glyoxalase I.
    Phillips GW; Norton SJ
    J Med Chem; 1975 May; 18(5):482-6. PubMed ID: 1171239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.
    Kavarana MJ; Kovaleva EG; Creighton DJ; Wollman MB; Eiseman JL
    J Med Chem; 1999 Jan; 42(2):221-8. PubMed ID: 9925727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyoxalase inhibitors. A possible approach to anticancer agents.
    Vince R; Daluge S
    J Med Chem; 1971 Jan; 14(1):35-7. PubMed ID: 5099673
    [No Abstract]   [Full Text] [Related]  

  • 20. Computer-automated structure evaluation of flavonoids and other structurally related compounds as glyoxalase I enzyme inhibitors.
    Klopman G; Dimayuga ML
    Mol Pharmacol; 1988 Aug; 34(2):218-22. PubMed ID: 3412324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.